Moyamoya Disease causes in adults
Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of the internal carotid arteries and their main branches at the base of the brain. While it is often diagnosed in children, it can also affect adults, and its causes in this age group are complex and multifaceted. Understanding these causes is crucial for early detection, management, and potentially preventing severe neurological outcomes.
In adults, the precise etiology of moyamoya disease remains largely unknown, but several factors are believed to contribute to its development. Genetic predisposition plays a significant role, as evidenced by familial cases and higher prevalence in certain populations, particularly those of East Asian descent. Studies have identified specific genetic markers, such as mutations in the RNF213 gene, which are strongly associated with moyamoya disease. These genetic factors may influence the structural integrity of blood vessel walls or the regulation of angiogenesis, leading to abnormal vessel narrowing.
Apart from genetic influences, structural abnormalities in blood vessel development are also implicated. During embryonic development, the arteries supplying the brain form through a complex process involving the growth and remodeling of vascular tissues. Any disruption or abnormality in this process can result in the progressive stenosis observed in moyamoya disease. In some cases, these vascular changes may be congenital, meaning present from birth, even if symptoms manifest later in life.
Environmental and acquired factors may also contribute to the development of moyamoya in adults. Certain conditions and systemic diseases are associated with secondary or “moyamoya syndrome,” which resembles primary moyamoya but occurs as a consequence of other underlying health issues. These include autoimmune disorders such as systemic lupus erythematosus or vasculitis, infections like tuberculosis, or a history of head trauma or radiation therapy. Such factors can induce inflammation or damage to the cerebral vessels, promoting progressive stenosis and collateral vessel formation.
Furthermore, atherosclerosis, a common cause of arterial narrowing in older adults, can sometimes mimic moyamoya’s vascular changes. However, true moyamoya disease involves a distinctive pattern of abnormal collateral vessel development that differs from typical atherosclerotic processes. Nonetheless, in some adult cases, it can be challenging to differentiate between primary moyamoya and secondary causes influenced by age-related vascular conditions.
Understanding the multifactorial causes of moyamoya in adults is essential because it influences treatment strategies. For example, addressing underlying systemic diseases or modifiable risk factors can help manage or slow disease progression. Additionally, genetic counseling may be recommended for families with a history of the condition. Ultimately, while genetic and developmental factors are primary contributors, environmental influences and systemic health also play vital roles, making moyamoya in adults a complex interplay of multiple causes.
In conclusion, the causes of moyamoya disease in adults encompass genetic predispositions, developmental anomalies, secondary influences from systemic diseases, and age-related vascular changes. Ongoing research continues to shed light on the intricate mechanisms behind this condition, paving the way for improved diagnosis, personalized treatment, and better patient outcomes.